BeOne Medicines
ONC
#670
Rank
HK$272.11 B
Marketcap
HK$2,459
Share price
2.94%
Change (1 day)
79.91%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

ESG Reports

Thumbnail BeOne Medicines ESG Report 2022

ESG Report 2022

Language: English

View ESG Report
Thumbnail BeOne Medicines ESG Report 2021

ESG Report 2021

Language: English

View ESG Report
Thumbnail BeOne Medicines ESG Report 2020

ESG Report 2020

Language: English

View ESG Report
Thumbnail BeOne Medicines ESG Report 2019

ESG Report 2019

Language: English

View ESG Report